Cargando…
MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension
Pulmonary hypertension is a devastating and refractory disease and there is no cure for this disease. Recently, microRNAs and mesenchymal stem cells emerged as novel methods to treat pulmonary hypertension. More than 20 kinds of microRNAs may participate in the process of pulmonary hypertension. It...
Autores principales: | Zhu, Zhaowei, Fang, Zhenfei, Hu, Xinqun, Zhou, Shenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541786/ https://www.ncbi.nlm.nih.gov/pubmed/26313730 http://dx.doi.org/10.5935/1678-9741.20150033 |
Ejemplares similares
-
A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model
por: Teng, Shuai, et al.
Publicado: (2023) -
New hope for a microRNA therapy for pulmonary arterial hypertension
por: Mehta, Jyoti, et al.
Publicado: (2013) -
Left Distal Transradial Approach for Coronary Intervention: Insights from Early Clinical Experience and Future Directions
por: Feng, Hao, et al.
Publicado: (2019) -
Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome
por: Tai, Shi, et al.
Publicado: (2020) -
Risk assessment model for predicting ventricular tachycardia or ventricular fibrillation in ST-segment elevation myocardial infarction patients who received primary percutaneous coronary intervention
por: Huang, Jiabing, et al.
Publicado: (2019)